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The zinc finger protein ZPR1 translocates from the cytoplasm to the nucleus after
treatment of cells with mitogens. The function of nuclear ZPR1 has not been defined.
Here we demonstrate that ZPR1 accumulates in the nucleolus of proliferating cells. The
role of ZPR1 was examined using a gene disruption strategy. Cells lacking ZPR1 are not
viable. Biochemical analysis demonstrated that the loss of ZPR1 caused disruption of
nucleolar function, including preribosomal RNA expression. These data establish ZPR1
as an essential protein that is required for normal nucleolar function in proliferating cells.
INTRODUCTION
ZPR1 is a zinc finger protein that is present in the cyto-
plasm of quiescent cells (Galcheva-Gargova et al., 1996).
Coimmunoprecipitation analysis demonstrates that
ZPR1 interacts with the cytoplasmic domain of receptor
tyrosine kinases, including the epidermal growth factor
(EGF) receptor. Deletion analysis indicates that this bind-
ing interaction is mediated by the zinc fingers (C-X2-C-
X25-C-X2-C) of ZPR1. The interaction between ZPR1 and
the cytoplasmic domain of the EGF receptor is disrupted
by treatment of cells with EGF. Thus, ZPR1 binds selec-
tively to the inactive EGF receptor. The mechanism used
by ZPR1 to discriminate between inactive and active
EGF receptors is unclear. However, the observation that
EGF does not regulate ZPR1 binding to kinase-negative
EGF receptors suggests that tyrosine phosphorylation is
required. Measurement of EGF-stimulated Shc phos-
phorylation in vivo indicates that the overexpression of
ZPR1 suppresses EGF receptor tyrosine kinase activity.
The cytoplasmic ZPR1 protein may therefore function to
repress the basal state of the EGF receptor tyrosine ki-
nase (Galcheva-Gargova et al., 1996).
Treatment with mitogens, including EGF, causes
translocation of cytoplasmic ZPR1 into the nucleus (Gal-
cheva-Gargova et al., 1996). The primary sequence of
ZPR1 does not contain an obvious nuclear localization
signal, and the mechanism of induced nuclear import
has not been defined. The binding interaction between
ZPR1 and the cytoplasmic domain of tyrosine kinase
receptors could serve as a mechanism of cytoplasmic
retention. However, analysis of the stoichiometry of the
ZPR1–receptor interaction indicates that the amount of
ZPR1 exceeds the amount of receptor in most cell types
(Galcheva-Gargova et al., 1996). Thus, retention by recep-
tors is insufficient to account for the cytoplasmic seques-
tration of ZPR1 in quiescent cells. Additional growth
factor-regulated mechanisms must therefore contribute
to induced nuclear accumulation of ZPR1.
The regulated nuclear accumulation of ZPR1 sug-
gests that this protein may function as a signaling
molecule. ZPR1 could participate in many nuclear
processes. For example, ZPR1 could be a regulated
transcription factor that is sequestered in the cyto-
plasm in latent form before activation, similar to NF-
kB, NFAT, STAT, or SMAD (Hunter, 1997). The pur-
pose of this study was to identify a nuclear function
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for ZPR1 in proliferating cells. We demonstrate that
nuclear ZPR1 accumulates within the nucleolus. Dis-
ruption of the ZPR1 gene causes defects in the bio-
chemical properties of the nucleolus. The ZPR1 pro-
tein may therefore contribute to the normal function of
the nucleolus in proliferating cells.
MATERIALS AND METHODS
Molecular Cloning of ZPR1
The human ZPR1 cDNA was isolated by screening a HeLa cDNA
library cloned in l phage (Stratagene, La Jolla, CA) using the murine
ZPR1 cDNA (Galcheva-Gargova et al., 1996) as a probe. Similar proce-
dures were used to isolate the Schizosaccharomyces pombe zpr11 and the
Saccharomyces cerevisiae ZPR1 genes by screening genomic libraries.
These clones were characterized by automated sequencing using an
Applied Biosystems (Foster City, CA) model 373A machine.
Immunofluorescence Analysis
HEp-2 and A431 cells were examined by immunofluorescence anal-
ysis using methods described previously (Galcheva-Gargova et al.,
1996). The cells were fixed with methanol (5 min, 220°C) followed
by acetone (2 min, 220°C). The cells were permeabilized with 0.1%
Triton X-100 and incubated with primary antibodies diluted in PBS.
Double-labeling experiments were performed using rabbit anti-
ZPR1 and characterized human polyclonal or mouse monoclonal
antibodies. Incubations were performed at 25°C (1 h). After exten-
sive washing, the cells were incubated with appropriate secondary
reagents (Caltag Laboratories, San Francisco, CA), washed, and
mounted on slides using Vectashield (Vector Laboratories, Burlin-
game, CA). The rabbit polyclonal antibody to ZPR1 has been de-
scribed (Galcheva-Gargova et al., 1996). Antisera to human p80
coilin (Andrade et al., 1991) and Pol I (Reimer et al., 1987b) were
provided by Dr. E.K.L. Chan (The Scripps Research Institute, La
Jolla, CA). The mouse monoclonal antibody to fibrillarin 72B9 (Rei-
mer et al., 1987a) was provided by Dr. K.M. Pollard (Scripps Re-
search Institute); the anti-DNA antibody 1.D12 (Kotzin et al., 1984)
was provided by Dr. R.L. Rubin (Scripps Research Institute); the
anti-SC-35 antibody (Fu and Maniatis, 1990) was provided by Dr.
X.-D. Fu (Harvard University, Cambridge, MA); and the anti-B23
monoclonal antibody was provided by Dr. I. Todorov (Desmos Inc.,
San Diego, CA) (Zatsepina et al., 1997).
Analysis of Yeast
Genetic and biochemical manipulation of S. pombe was done using
standard techniques (Moreno et al., 1991). Disruption of the zpr11
gene was done by insertion of the ura41 gene (1.7-kb BamHI–HindIII
fragment) in the BstE2 and EcoRV sites of the zpr11 coding region
(2.9-kb XbaI fragment). The disrupted zpr11 genomic clone (4.6-kb
XbaI fragment) was transformed in the diploid strain 480. Disrup-
tion of the zpr11 gene was confirmed by Southern blot analysis of
genomic DNA isolated from transformants. The heterozygous dip-
loid strain was designated TE630 [zpr1::ura41/zpr11, ade6-M210/
ade6-M216, ura4-d18/ura4-d18, leuI-32/leuI-32, h2/h1]. Control hap-
loid isogenic strains isolated by tetrad analysis were designated
TE331 and TE332 [ade6-M210, ura4-d18, leuI-32 h1 (or h2)].
Complementation studies were done using the promoterless vec-
tor pIRT2 and the nmt promoter vector pREP41. The S. pombe zpr11
gene (2.9-kb XbaI fragment) was cloned into the SmaI site of pIRT2.
Regulated expression vectors for S. pombe zpr11, S. cerevisiae ZPR1,
and murine ZPR1 were constructed by cloning PCR fragments in
the polylinker of pREP41. The yeast strain TE630 was transformed,
and haploid yeast were selected on plates supplemented with ade-
nine. The growth of the haploid yeast was examined on agar plates
and liquid minimal medium in the absence and presence of thia-
mine (10 mM). Cells grown to midlog phase in liquid culture were
used for RNA isolation, [35S]methionine labeling, and microscopy
using standard procedures. The RNA was examined by Northern
blot analysis by probing with a random-primed PCR fragment (bp
150-1120) corresponding to the 59 external transcribed spacer (ETS)
region of S. pombe pre-rRNA (GenBank accession number Z19578).
The sequences of the murine ZPR1 cDNA, the human ZPR1
cDNA, the S. pombe zpr11 gene, and the S. cerevisiae ZPR1 gene have
been deposited in GenBank with accession numbers U41287,
AF019767, AF019768, and AF019769, respectively.
RESULTS
ZPR1 Is Localized in a Subregion of the Nucleus
The mammalian ZPR1 protein is located in the cyto-
plasm of serum-starved cells (Galcheva-Gargova et al.,
1996). Treatment with growth factors leads to the ac-
cumulation of ZPR1 in the nucleus (Galcheva-
Gargova et al., 1996). This redistribution of ZPR1 from
the cytoplasm to the nucleus was detected in cells
treated with EGF (Figure 1). The intranuclear distri-
Figure 1. The cytoplasmic ZPR1 protein redistributes to the nucleus of mitogen-activated cells. A431 cells were incubated without
(STARVED) and with 100 nM EGF for 15 min. The cells were processed for immunofluorescence microscopy using an antibody to ZPR1.
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bution of ZPR1 was punctate in appearance. To gain in-
sight into the function of ZPR1, we examined the sub-
nuclear localization of ZPR1. Immunofluorescence analysis
of serum-treated human HEp-2 cells demonstrated staining
of the nucleoplasm with a distinct punctate appearance.
Double-label immunofluorescence analysis demonstrated
that the punctate ZPR1 staining colocalized extensively
with fibrillarin and RNA Pol I, but not with splicing factor
SC35 or p80 coilin (Figure 2). These data indicate that ZPR1
may accumulate within the nucleolus.
Comparison of the intranuclear staining of fibrillarin and
RNA Pol I with ZPR1 indicates that the distribution of these
proteins is not identical. For example, fibrillarin is located in
both coiled bodies and the nucleolus. In addition, both
fibrillarin and RNA Pol I are located within specific subre-
gions of the nucleolus. The nucleolus is composed of sep-
arate regions, including fibrillar centers, the dense fibrillar
component, and the granular component (Shaw and Jor-
dan, 1995). Each of these components is thought to corre-
spond to a different functional region of the nucleolus.
Because these regions are interspersed, it is not possible to
determine the subnucleolar localization of ZPR1 by immu-
nofluorescence microscopy. However, the nucleolus can be
segregated into fibrillar and granular regions using drugs
(Simar and Bernhardt, 1966; Ochs et al., 1985). For example,
at low doses, actinomycin D intercalates into GC-rich re-
gions of DNA and markedly inhibits Pol I transcription of
rRNA (Abelson and Penman, 1975). Treatment of HEp-2
Figure 2. Nuclear ZPR1 accumulates
in the nucleolus. Activated HEp-2 cells
were examined by laser scanning con-
focal microscopy using antibodies to
ZPR1 (FITC, green) and nuclear anti-
gens (rhodamine, red). In the merged
image, fibrillarin and RNA Pol I show
extensive colocalization (yellow),
whereas p80 coilin and SC35 splicing
factor show extensive segregation
(green and red). Bar, 35 mm. Fibrillarin
and RNA Pol I are markers for the
nucleolus.
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cells with actinomycin D caused the formation of fibrillar
caps (stained with an antibody to fibrillarin) and the rapid
dissociation of ZPR1 from the nucleolus (Figure 3A). These
data indicated that ZPR1 was not located in the same
compartment of the nucleolus as fibrillarin. Because actino-
mycin D causes some disruption of the granular region of
the nucleolus (Yung et al., 1985), it is possible that ZPR1
may be located within the granular component of the nu-
cleolus. To test this hypothesis, we examined the effect of
the adenosine analogue 5,6-dichloro-b-d-ribofuranosylben-
zimidazole (DRB), which induces segregation of nucleolar
components without altering the ultrastructural character-
istics of the fibrillar and granular compartments (Granick,
1975). These experiments demonstrated that ZPR1 did not
colocalize with either a marker for the fibrillar component
(fibrillarin) (Figure 3B) or the granular component (B23) of
the segregated nucleolus (Figure 3C). In the absence of
DRB, it is possible that ZPR1 may associate with either the
fibrillar or the granular component of the nucleolus in
proliferating cells. Further studies are required to resolve
this question.
RNA Is Required for the Nucleolar Localization of
ZPR1
The nucleolus is the major site of transcription of
rRNA genes and the processing of rRNA into preri-
bosomal particles (Woolford and Warner, 1991; Shaw
and Jordan, 1995). The nucleic acid composition of the
nucleolus differs from other regions of the nucleus
because of the abundance of rRNA genes and rRNA
transcripts. This distinctive nucleic acid composition
(both DNA and RNA) may contribute to the accumu-
lation of ZPR1 in the nucleolus. To examine the pos-
sible role of nucleic acids, we investigated the effect of
nuclease digestion on ZPR1 localization by immuno-
fluorescence microscopy. Digestion of permeabilized
cells with DNase I caused a marked decrease in nu-
clear DNA, which was detected using a monoclonal
antibody to DNA (Figure 4A). However, this treat-
ment did not affect the nucleolar location of ZPR1
(Figure 4A). In contrast, digestion with RNase A
caused a marked decrease in the nucleolar location of
ZPR1 (Figure 4B). Control studies demonstrated that
RNase A digestion did not alter nuclear DNA (our
unpublished results) but did reduce the nuclear accu-
mulation of small nuclear ribonuclear protein (snRNP)
(Figure 4B). Together, these data indicate that the nu-
cleolar localization of ZPR1 requires RNA but not
DNA. The requirement for RNA suggests that ZPR1
nucleolar localization may be mediated by the inter-
action of ZPR1 (directly or indirectly) with RNA.
The Zinc Finger Protein ZPR1 Is Conserved in
Mammals and Yeast
The ZPR1 protein was first identified in mice (Galcheva-
Gargova et al., 1996). A human homologue was iden-
Figure 3. ZPR1 is not an integral component of the fibrillar
or granular components of the nucleolus. Proliferating
HEp-2 cells were treated (4 h) with 0.1 mg/ml actinomycin
D or with 25 mg/ml of the adenosine analogue DRB, fixed,
and processed for immunofluorescence microscopy using
antibodies to ZPR1 (FITC, green) and antibodies that stain
the fibrillar component (fibrillarin; rhodamine, red) and the
granular component (B23; rhodamine, red) of the nucleolus.
Cells treated with actinomycin D were stained with ZPR1
and fibrillarin (A). Cells treated with DRB were stained with
antibodies to ZPR1 and fibrillarin (B) or ZPR1 and B23 (C).
A photomicrograph of the differential interference contrast
(DIC) image is presented in each panel.
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tified by screening a cDNA library for sequences re-
lated to ZPR1. The human ZPR1 protein deduced from
the sequence of cDNA clones is similar to mouse ZPR1
(Figure 5). Homologues of ZPR1 were also identified
in yeast, including the budding yeast S. cerevisiae and
the fission yeast S. pombe (Figure 5). Comparison of the
sequence of the mammalian and yeast ZPR1 proteins
demonstrates that they share conserved structural mo-
tifs, including the presence of two zinc fingers (C-X2-
C-X25-C-X2-C). The presence of two molecules of zinc
per molecule of ZPR1 was confirmed by atomic ab-
sorbtion spectroscopy (Galcheva-Gargova et al., 1996).
The high level of conservation of ZPR1 between mam-
mals and yeast indicates that ZPR1 is likely to serve an
important basic physiological function.
Gene Disruption Studies Demonstrate That ZPR1 Is
Essential for Cell Viability
We examined the effect of disruption of the ZPR1 gene.
These studies were facilitated by the identification of
ZPR1 in fission and budding yeast (Figure 5). We fo-
cused our analysis on the zpr11 gene of the fission yeast
S. pombe. We used homologous recombination to disrupt
the zpr11 gene by replacement with the ura41 gene
(Figure 6, A and B). These heterozygous diploid yeast
were sporulated and examined by tetrad analysis (Fig-
ure 6C). Viability segregated 2:2, and none of the viable
haploid colonies were ura41. Thus, zpr11 is an essential
gene in S. pombe. Similar studies demonstrated that the
ZPR1 gene was also essential for viability in S. cerevisiae
(our unpublished results).
To demonstrate that the loss of viability was caused by
the disruption of the zpr11 gene, we performed comple-
mentation analysis using plasmid vectors that express
zpr11. We found that a 2.9-kb XbaI genomic fragment
that contained the zpr11 gene complemented the loss of
viability caused by the disrupted zpr11 allele (our un-
published results). Furthermore, complementation was
observed in experiments using a plasmid vector
(pREP41-zpr1) in which the zpr11 coding sequence was
expressed under the control of the nmt promoter (Figure
6D). Repression of the nmt promoter with thiamine did
not affect the growth of the control (zpr11) strain trans-
formed with pREP41-zpr1. In contrast, thiamine mark-
edly decreased the growth of the zpr1::ura41 strain (Fig-
ure 6D). Similar results were obtained in complementa
tion studies using S. cerevisiae and murine ZPR1 (Figure
6D). The observation of complementation by both mam-
malian and yeast ZPR1 indicates that the biological func-
tion of ZPR1 has been conserved during evolution.
We performed quantitative analysis of the effect of
thiamine-induced repression of zpr11 on the growth of
yeast transformed with pREP41-zpr1 in liquid culture.
These experiments were performed using haploid yeast
(zpr11 and zpr1::ura41 strains) that express the zpr11
gene from the thiamine-repressible nmt promoter. Thia-
mine caused no change in the growth of the zpr11 strain
in liquid cultures but caused decreased growth of the
zpr1::ura41 strain (Figure 7A). Microscopic analysis dem-
onstrated that the zpr11 strain consisted of a population
of yeast that were distributed throughout the cell cycle,
including both large and small yeast (Figure 7B). In
contrast, cultures of the zpr1::ura41 strain contained a
more uniform population of small yeast (Figure 7B). The
morphology of the zpr1::ura41 strain is consistent with a
growth-arrested phenotype.
Repression of zpr11 Causes Defects in Nucleolar
Function
Because zpr11 is an essential gene and the ZPR1 pro-
tein is located in the nucleolus of proliferating cells,
we examined whether the repression of zpr11 expres-
Figure 4. RNA is required for the nucleolar localization of ZPR1.
HEp-2 cells were grown on microscopic slides, permeabilized with
0.1% Triton X-100 for 3 min on ice, washed, and digested (60 min at
37°C) with 0.1 mg/ml DNase I in PBS containing 5 mM MgCl2 or
with 0.1 mg/ml RNase A in PBS. The cells were washed in PBS and
processed for indirect immunofluorescence. Buffers without en-
zymes served as negative controls. A human antibody to snRNP or
a monoclonal antibody to DNA was used to monitor the efficiency
of DNase I and RNase A digestions, respectively. The effect of
DNase I (A) and RNase A (B) is presented.
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sion caused defects in nucleolar function. The nucleo-
lus is the major site of transcription of rRNA genes.
We therefore investigated rRNA expression in haploid
yeast (zpr11 and zpr1::ura41 strains) that express the
zpr11 gene from the thiamine-repressible nmt pro-
moter (Figure 7C). RNA was prepared from these
yeast strains cultured in the absence and presence of
thiamine. The yield of total RNA from the thiamine-
treated zpr1::ura41 strain was reduced compared with
the wild-type zpr11 strain. The decreased amount of
total RNA is accounted for, at least in part, by de-
creased amounts of rRNA. However, there was no
change in the ratio of the mature 18 and 25S rRNA.
The decreased amount of mature rRNA suggests that
rRNA expression may be altered by repression of
zpr11 gene expression. To test this hypothesis, we
examined the 35S rRNA precursor by Northern blot
analysis of 10 mg of total RNA (Figure 7C). This anal-
Figure 5. The ZPR1 gene is highly conserved in mammals and yeast. The sequences of the human, mouse, and yeast (S. pombe and S.
cerevisiae) ZPR1 proteins were compared using the PILE-UP program (version 7.2; Wisconsin Genetics Computer Group, Madison, WI).
Residues that are identical with human ZPR1 are indicated with a period. Gaps were introduced to optimize the alignment (–). The two zinc
fingers are overlined, and the Cys residues are indicated with asterisks. The sequence of mouse ZPR1 (GenBank accession number U41287)
has been reported (Galcheva-Gargova et al., 1996). The human and yeast ZPR1 protein sequences were deduced from the nucleotide sequence
of HeLa cDNA clones isolated from a lZAP II phage library (Stratagene) and from the sequence of yeast genomic clones. The sequences of
the human ZPR1 cDNA, the S. pombe zpr11 gene, and the S. cerevisiae ZPR1 gene have been deposited in GenBank with accession numbers
AF019767, AF019768, and AF019769, respectively.
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ysis demonstrated that the thiamine-induced repres-
sion of zpr11 gene expression in the zpr1::ura41 strain
caused a marked reduction in the accumulation of 35S
pre-rRNA. Control experiments using the wild-type
strain (zpr11) demonstrated that thiamine caused no
change in the accumulation of 35S pre-rRNA. These
data demonstrate that zpr11 is required for the accu-
mulation of the rRNA precursor.
The ribosome is the cellular machine that is used for
protein synthesis. If zpr11 is required for rRNA ex-
pression, then the repression of zpr11 gene expression
should have consequences on protein synthesis. We
therefore examined the effect of repression of zpr11
gene expression on protein synthesis. Liquid cultures
of these yeast were incubated with [35S]methionine for
3 h, and the incorporation of radioactivity into protein
was examined after SDS-PAGE by autoradiography
(Figure 7D). Addition of thiamine to the zpr11 strain
caused no change in the incorporation of [35S]methi-
onine (Figure 7D, lanes 4–6). The extent of [35S]methi-
onine incorporation was similar to that observed in
experiments using the zpr1::ura41 strain grown in the
absence of thiamine (Figure 7D, lane 1). In contrast,
addition of thiamine to the zpr1::ura41 strain caused a
marked reduction in protein synthesis (Figure 7D,
lane 3). A partial recovery of protein synthesis was
observed if thiamine was omitted from the culture
during the incubation with [35S]methionine (Figure
7D, lane 2). Together, these data demonstrate that the
loss of zpr11 expression interferes with protein bio-
synthesis. The marked reduction in protein synthesis
may account for the small size and reduced growth of
the zpr1::ura41 strain (Figure 7, A and B).
DISCUSSION
ZPR1 was initially identified in the mouse (Galcheva-
Gargova et al., 1996). Human ZPR1 was found to be
very similar to the mouse protein (Figure 5). Exami-
nation of ZPR1 expression in other organisms identi-
fied homologues of ZPR1 in the budding yeast S.
cerevisiae and the fission yeast S. pombe (Figure 5).
Gene disruption studies demonstrated that ZPR1 is an
essential gene in fission yeast (Figure 6) and budding
yeast (our unpublished results). The lethal phenotype
in fission yeast was complemented by expression of
yeast or mammalian ZPR1 proteins (Figure 6). The
identification of ZPR1 as an essential gene that has
been conserved during evolution indicates that ZPR1
serves a similar function in many cell types.
The ZPR1 protein is located in the cytoplasm of qui-
escent mammalian cells. However, in proliferating cells,
ZPR1 translocates to the nucleus (Galcheva-
Gargova et al., 1996). The mechanism that controls the
nuclear redistribution of ZPR1 in proliferating cells is not
understood. However, it is possible that the interaction
of ZPR1 with cell surface receptor tyrosine kinases may
contribute to the cytoplasmic sequestration of ZPR1 in
quiescent cells (Galcheva-Gargova et al., 1996). Treat-
Figure 6. The zpr11, gene is essential for cell viability. (A) The S.
pombe zpr11 gene was disrupted by homologous recombination. The
structure of the zpr11 genomic locus and the disrupted gene
(zpr1::ura41) is presented schematically. (B) Southern blot analysis
of the diploid yeast transformants. The genomic DNA was restricted
with BglII and probed with a random-primed fragment of the zpr11
genomic locus (2.9-kb XbaI fragment). The wild-type zpr11 allele
was identified in wild-type yeast (strain 480; lane 1). The disrupted
zpr1::ura41 allele (3 kb) was identified in some (lanes 2 and 4) but
not all (lane 3) transformants. (C) The heterozygous diploid yeast
strain TE630 (zpr11/zpr1::ura41) was sporulated, and the tetrads
were dissected. The viability of the spores was examined by growth
on agar plates supplemented with uracil. (D) The heterozygous
(zpr11/zpr1::ura41) diploid yeast strain TE630 was transformed
with the plasmid pREP41 or the plasmid pREP41-zpr1, selected on
minimal agar plates without leucine and uracil, and sporulated, and
haploid yeast were selected on minimal media supplemented with
adenine. No viable haploid yeast (zpr1::ura41) were obtained from
diploid yeast transformed with pREP41. However, the zpr1 expres-
sion vector pREP41-zpr1 complemented the lethal phenotype of the
disrupted zpr11 gene. Complementation was observed in experi-
ments using S. pombe zpr11, S. cerevisiae ZPR1, and murine ZPR1.
Repression of the nmt promoter in the pREP plasmid with thiamine
decreased the growth of the complemented ZPR::ura41 haploid
strains, but not the wild-type zpr11 haploid strain transformed with
pREP41-zpr1.
Redistribution of ZPR1 to the Nucleolus
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ment of mammalian cells with mitogens causes the dis-
sociation of ZPR1 from receptor tyrosine kinases and the
translocation of ZPR1 to the nucleus. Whether the bind-
ing of ZPR1 to tyrosine kinase receptors in quiescent
cells is mechanistically related to the cytoplasmic reten-
tion of ZPR1 is unclear. Interestingly, the nuclear redis-
tribution of ZPR1 observed in mammalian cells is also
observed in yeast. Thus, ZPR1 is a nuclear protein in
Figure 7. Loss of zpr11 function causes depletion of the rRNA precursor and decreased protein translation. (A) Wild-type haploid S. pombe
(zpr11) and the zpr1::ura41 disrupted strain were transformed with the plasmid pREP41-zpr1 and grown in minimal liquid medium. The
cultures were divided into two flasks in the absence (open symbols) and presence (closed symbols) of thiamine, respectively. Thiamine is a
repressor of the nmt promoter located in the pREP plasmid. The growth of the cultures was monitored by measurement of the optical density
at 595 nm. (B) The morphology of the yeast grown in the presence of thiamine (12 h) was examined by phase-contrast microscopy. DNA
stained with 4,6-diamidino-2-phenylindole was visualized by epifluorescence. Bar, 10 mm. (C) Northern blot analysis of RNA isolated from
the zpr11 and the zpr1::ura41 disrupted S. pombe strains transformed with the plasmid pREP41-zpr1. The yeast were grown in the absence
and presence of the repressor thiamine (12 h). Ten micrograms of RNA isolated from these yeast were examined by denaturing agarose gel
electrophoresis. The 25 and 18S mature rRNA were detected by staining with ethidium bromide (bottom panel). The 35S rRNA precursor was
detected by Northern analysis using a 59-ETS probe. An autoradiogram of the dried blot is shown (top panel). (D) Wild-type and zpr1::ura41
disrupted strains were grown in the absence (lanes 1 and 4) and presence (lanes 2, 3, 5, and 6) of the repressor thiamine (12 h). The cells were
diluted to the same density (0.2 OD595), labeled with [35S]methionine (150 mCi/ml) for 3 h, and harvested. The labeling with [35S]methionine
was performed in the absence (lanes 1, 2, 4, and 5) and presence (lanes 3 and 6) of thiamine. Extracts prepared from the yeast were examined
by SDS-PAGE and autoradiography.
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proliferating yeast and is a cytoplasmic protein in
growth-arrested yeast (our unpublished results). This
observation indicates that the growth-associated redis-
tribution of ZPR1 from the cytoplasm to the nucleus is
conserved in mammals and yeast. This conservation of
function suggests that the mechanism of nuclear redis-
tribution of ZPR1 may also be conserved in yeast and
mammals. It is likely that a conserved mechanism would
not involve cytoplasmic retention by cell surface recep-
tor tyrosine kinases because such molecules are not ex-
pressed in yeast. Clearly, further studies are required to
define the mechanism of proliferation-associated nuclear
redistribution of ZPR1 and to determine the significance
of the interaction of ZPR1 with receptor tyrosine kinases
in mammalian cells.
Immunofluorescence analysis demonstrated that
ZPR1 is accumulated within a subnuclear compartment,
the nucleolus (Figure 2). Fractionation experiments dem-
onstrated that ZPR1 was not an integral component of
the fibrillar or granular compartments of the nucleolous
(Figure 3), suggesting that either ZPR1 is peripherally
associated with one of these nucleolar compartments or
is located in a distinct subregion of the nucleolus. How-
ever, the nucleolar location of ZPR1 required RNA, sug-
gesting that nucleolar integrity was required for the ac-
cumulation of ZPR1 (Figure 4). The movement of ZPR1
from the cytoplasm to the nucleolus in response to pro-
liferative signals indicates that ZPR1 may have a signal-
ing role. However, the nuclear function of ZPR1 has not
been established by previous studies (Galcheva-Gargova
et al., 1996).
The major functions of the nucleolus are thought to be
the transcription of rRNA genes, the processing of the
pre-rRNA precursor to form mature rRNA, and the as-
sembly of rRNA into preribosomal particles (Shaw and
Jordan, 1995). Because ZPR1 is a nucleolar protein that is
essential for cell viability, a plausible role for ZPR1 is to
contribute to one step in the process of rRNA expression.
Consistent with this hypothesis, we found that the re-
pression of zpr11 gene expression in fission yeast caused
a marked decrease in the level of pre-rRNA (Figure 7C).
This decreased rRNA is likely to account for the growth
arrest (Figure 7A) and decreased protein translation (Fig-
ure 7D) observed after repression of zpr11 gene expres-
sion.
The results of the present study provide direct exper-
imental evidence that the cytoplasmic protein ZPR1 re-
distributes to the nucleolus in proliferating cells and that
ZPR1 is required for normal nucleolar function. Further
studies are required to determine the molecular basis for
the role of ZPR1 in these processes.
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